UnknownPhase 3NCT04862377

Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Clinic of Barcelona
Principal Investigator
Marta Teresa-Palacio, MD, MD
Hospital Clinic of Barcelona
Intervention
Poractant Alfa Intratracheal Suspension [Curosurf](drug)
Enrollment
50 enrolled
Eligibility
All sexes
Timeline
20212026

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04862377 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials